These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 797446)

  • 1. Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval).
    Greco FA; Brereton HD; Rodbard D
    Cancer Treat Rep; 1976 Sep; 60(9):1239-45. PubMed ID: 797446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity.
    Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ
    Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy in the multimodal management of Ewing's sarcoma of bone: report of the Intergroup Ewing's Sarcoma Study.
    Perez CA; Tefft M; Nesbit ME; Burgert EO; Vietti TJ; Kissane J; Pritchard DJ; Gehan EA
    Natl Cancer Inst Monogr; 1981 Apr; (56):263-71. PubMed ID: 7029294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10.
    Cortes EP; Gupta M; Chou C; Amin VC; Folkers K
    Cancer Treat Rep; 1978 Jun; 62(6):887-91. PubMed ID: 667863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiotoxicity in long term treatment with cytostatics (author's transl)].
    Fuhrmann U; Rieger M; Franz Ch
    Dtsch Med Wochenschr; 1978 Mar; 103(9):387-90. PubMed ID: 272983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
    Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is the use of adriamycin (doxorubicin) limited by its cardiotoxicity?].
    Reinhardt D; Hofmann V; Martz G
    Schweiz Med Wochenschr; 1985 Apr; 115(16):557-61. PubMed ID: 4001904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Status of adriamycin in cancer therapy].
    Berndt H
    Arch Geschwulstforsch; 1982; 52(7):585-96. PubMed ID: 7165492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity.
    Chlebowski RT; Paroly WS; Pugh RP; Hueser J; Jacobs EM; Pajak TF; Bateman JR
    Cancer Treat Rep; 1980 Jan; 64(1):47-51. PubMed ID: 7379058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electrocardiogram analysis of adriamycin cardiotoxicity in 160 cases].
    Wang SQ
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):71-3. PubMed ID: 1889343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adriamycin (doxorubicin) cardiotoxicity: a review.
    Chlebowski RT
    West J Med; 1979 Nov; 131(5):364-8. PubMed ID: 394479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adriamycin and mitomycin C: possible synergistic cardiotoxicity.
    Buzdar AU; Legha SS; Tashima CK; Hortobagyi GN; Yap HY; Krutchik AN; Luna MA; Blumenschein GR
    Cancer Treat Rep; 1978 Jul; 62(7):1005-8. PubMed ID: 688243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
    Bacci G; Ferrari S; Rosito P; Barbieri E; Mercuri M; Brach del Prever A; Iantorno D; Forni C; Campanacci M
    Minerva Pediatr; 1995 Nov; 47(11):457-69. PubMed ID: 8684341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.
    Swain SM; Whaley FS; Ewer MS
    Cancer; 2003 Jun; 97(11):2869-79. PubMed ID: 12767102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intraarterial high-dose adriamycin for patients with skeletal or soft tissue sarcoma].
    Yoh S; Takagishi N; Iwasaki H; Eimoto T; Ono Y; Okasaki M
    Gan No Rinsho; 1983 Aug; 29(10):1263-73. PubMed ID: 6632206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal therapy in metastatic Ewing's sarcoma: an Intergroup Study.
    Vietti TJ; Gehan EA; Nesbit ME; Burgert EO; Pilepich M; Tefft M; Kissane J; Pritchard DJ
    Natl Cancer Inst Monogr; 1981 Apr; (56):279-84. PubMed ID: 7029296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiotoxicity of mitoxantrone].
    Okuma K; Ariyoshi Y; Ota K
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3040-5. PubMed ID: 3464231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of a new induction protocol in Ewing's sarcoma. Apropos of 35 cases].
    Desbois JC; Delepine N; Delepine G; Housset M; Cornille H; Favre R; Tubiana Hulin M; Touzet P; Jasmin C
    Ann Med Interne (Paris); 1989; 139(8):534-6. PubMed ID: 2729811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
    Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac function and cardiopulmonary performance in patients after treatment for non-Hodgkin's lymphoma.
    Elbl L; Vasova I; Tomaskova I; Jedlicka F; Navratil M; Pospisil Z; Vorlicek J
    Neoplasma; 2006; 53(2):174-81. PubMed ID: 16575475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.